skinbetter curated a skin-renewing trio to address the side effects of GLP-1 treatments, restore firmness, target the cause of skin aging at the root, and visibly reduce telltale signs like crow's feet. Offering support from the inside out, and outside in, this skincare trio includes a BioRewind skin health dietary supplement, plus the InterFuse Treatment Cream FACE & NECK, and Interfuse Treatment Cream EYE, leveraging patented CORExtract biotechnology, proprietary InterFuse Technology, and a neuro-calming peptide.
The rise of GLP-1 medications has implications beyond the health and wellness industry, and skincare brands are responding to the increased demand for solutions that address facial volume loss—sometimes referred to "Ozempic face" or "GLP-1 face"—with new products, as well as fresh messaging that brings newfound attention to existing treatments proven to enhance skin elasticity and firmness.
What's Driving This Trend
- Integrative Skincare Supplements
- The convergence of dietary supplements and topical treatments in skincare presents a new approach to holistic beauty solutions.
- Biotechnology-driven Skincare
- As skincare products increasingly utilize advanced biotechnology, they offer more effective and targeted treatments for various skin concerns.
- Neuro-calming Skincare Innovations
- Skincare lines incorporating neuro-calming peptides are growing in popularity as consumers seek products that provide both aesthetic and soothing benefits.
Who This Affects Most
- Skincare
- The skincare industry is witnessing a shift towards more sophisticated treatments that tackle specific side effects of medical interventions like GLP-1 therapies.
- Pharmaceuticals
- Pharmaceutical companies are finding new opportunities for cross-industry collaboration as skincare brands develop products to address drug side effects.
- Biotechnology
- Biotechnology firms are playing a pivotal role in the development of innovative skincare solutions that promise enhanced efficacy and targeted results.
